Viking Therapeutics logo
Viking Therapeutics VKTX
$ 62.26 0.78%

Viking Therapeutics Cash Flow 2011-2024 | VKTX

Annual Cash Flow Viking Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-73.4 M -48.4 M -47.6 M -21.8 M -24.8 M -18.8 M -14.8 M - - - - - -

Depreciation & Amortization

- - - - - - - - - - - - -

Accounts Payables

7.51 M 8.53 M 1.44 M 3.99 M 2.43 M 959 K 1.53 M 1.2 M 592 K - - - -

Accounts Receivables

- - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow Viking Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - -24.6 M - -37.5 M - -10.5 M - -35.2 M - -10.9 M - -16.3 M -11 M -4.3 M - -13 M -9.61 M -3.15 M - -16.1 M -10.6 M -5.3 M - -10.8 M -7.48 M - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

5.71 M 5.61 M 3.8 M 8.53 M 3.14 M - 3.12 M 1.44 M 2.85 M 4.21 M 4.85 M 3.99 M 3.99 M 3.99 M 3.99 M 2.43 M 2.43 M 2.43 M 2.43 M 959 K 959 K 959 K 959 K 1.53 M 1.53 M 1.53 M 1.53 M 1.2 M 1.2 M 1.2 M 1.2 M 592 K 592 K 592 K 592 K 1.83 M 1.83 M 1.83 M 1.83 M - - - - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency